EDGAR Filing Documents for 0001171843-15-005643

Form 8-K - Current report:

SEC Accession No. 0001171843-15-005643

Filing Date

2015-10-22

Accepted

2015-10-22 07:31:49

Documents

Period of Report

2015-10-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gff8k_102215.htm	8-K	28147
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	7728
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	7438
4	GRAPHIC	logo.jpg	GRAPHIC	3125
	Complete submission text file	0001171843-15-005643.txt		49079

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 151169091
SIC: 2834 Pharmaceutical Preparations